Lanean...
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate
Abemaciclib, an inhibitor of cyclin dependent kinases 4 and 6, is indicated for metastatic breast cancer treatment. Reversible increases in serum creatinine levels of ~15–40% over baseline have been observed following abemaciclib dosing. This study assessed the in vitro and clinical inhibition of re...
Gorde:
| Argitaratua izan da: | Clin Pharmacol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465099/ https://ncbi.nlm.nih.gov/pubmed/30449032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1296 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|